Various medical supplies and reagents used to test for compatibility of blood products.
Ended Awarded
- Contract number
- N0025922F0024
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $54,330
Award facts
- Contract value 100% obligated
- $54,329.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
About this award
On December 7, 2021, the Defense Health Agency awarded a delivery order valued at $54.3K to Immucor Inc. for various medical supplies and reagents used to test for compatibility of blood products. The contract, which was completed by December 30, 2022, operates under a firm fixed-price structure with no set-aside designation. Immucor, a for-profit manufacturer headquartered in Norcross, Georgia, specializes in in vitro diagnostic products and blood banking solutions. Performance of this delivery order took place in Norcross, Georgia, leveraging the vendor's established capabilities in blood transfusion and transplantation compatibility testing.
This delivery order is issued under the General Services Administration Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, a master contract vehicle that streamlines procurement of diagnostic supplies across federal agencies. Immucor maintains a strong portfolio of federal contracts with multiple defense and healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and various military commands. The company holds several significant Indefinite Delivery/Indefinite Quantity agreements with the Defense Health Agency, including a $1.02M blanket purchase agreement extending through March 2027, which provides the framework for recurring task orders such as this one to support blood banking operations and transfusion medicine requirements across federal healthcare networks.
Quick answers
Who was awarded contract N0025922F0024?
N0025922F0024 was awarded to Immucor Inc. by Bureau of Medicine and Surgery (Department of the Navy) on December 7, 2021.
How much is contract N0025922F0024 worth?
The government has obligated $54,330 on N0025922F0024.
Which agency awarded contract N0025922F0024?
Bureau of Medicine and Surgery (Department of the Navy) awarded N0025922F0024, with funding from Defense Health Agency (Department of Defense).
Is contract N0025922F0024 an order under another contract?
Yes. N0025922F0024 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N0025922F0024 competed?
The extent of competition for N0025922F0024 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award